Dogwood Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $29.9M | $29.8M |
| FY2021 | — | $14.5M | $14.0M |
| FY2022 | — | $7.3M | $7.0M |
| FY2023 | — | $3.8M | $3.3M |
| FY2024 | — | $-10.1M | $14.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $29.9M | $29.8M |
| FY2021 | — | $14.5M | $14.0M |
| FY2022 | — | $7.3M | $7.0M |
| FY2023 | — | $3.8M | $3.3M |
| FY2024 | — | $-10.1M | $14.8M |